In vitro inhibition of avian pathogenic Enterococcus cecorum isolates by probiotic Bacillus strains

    ABSTRACT Enterococcus cecorum is a commensal bacteria and opportunistic pathogen that can cause outbreaks of Enterococcal spondylitis (“kinky back”) in poultry, with a growing concern worldwide. Numerous Bacillus-based probiotic strains are commercially available with proven effects in supporting gut health and growth performance, but efficacy against pathogenic E. cecorum is unknown. This study compared the in vitro inhibitory potential of cell-free supernatants (CFSs) of 18 Bacillus strains (14 commercial probiotic strains, 1 internal negative control and 3 type strains) on the growth of 9 clinical E. cecorum isolates. Standardized biomass cultures of live Bacillus were harvested and filtered to obtain CFSs. Inhibitory potential against E. cecorum isolates was assessed via a microdilution assay in which the final pathogen concentration was ∼ 104 CFU/mL. ....
    Document information
    Product / service: Probiotics
    Publication date: 18/01/2019
    Species: Multi-species
    Authors: Bernardeau M, Cretenet, Marina, Fernandez, Sara Medina
    Doctype: Publications & Citations
    Publication / conference: Poultry Science
    Regions and countries:
    Keywords: bacillus, enteric disease, pathogens, probiotic
    Production challenge(s):
    Diets: All diets
    Brands: Enviva® Pro
    Resource ref:
    Recently viewed

    Your single source for articles, publications & citations, product information and more...

    Much of the content on this site is freely available. Register now to receive email notifications based on your content preferences. Partners may also request access to the restricted area of the Knowledge Centre for technical product information such as trial data, reports and much more.

    Register for content notifications

    DuPont's Nutrition & Biosciences and IFF are coming together

    This isn't about forming another industry giant. This is about merging curiosity and capability to create unique, leading-edge solutions at the intersection of science and creativity.

    To learn more about IFF and the merger, go to www.iff.com.